Store
Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition
Publication Date: April 18, 2023
Tags: COVID-19, Diagnostic Instruments, Infectious Disease Testing Instruments, Oncology and Cancer, Point-of-Care (POC) Testing
Pages: 600
SKU: 23-031
The point-of-care diagnostics market represents a key opportunity within the in vitro diagnostics (IVD) industry. The 10th edition of Kalorama Information’s annual market research study on point-of-care (POC) devices is the most comprehensive resource for anyone involved in this rapidly growing segment. While lab-based analyzers remain the foundation of IVD revenues, POC diagnostics are the area of significant growth, attracting substantial investment and numerous companies.
Comprehensive and Reliable Market Insights:
Now in its 10th edition, Kalorama’s report is trusted by top POC IVD companies for its objective, well-supported estimates of market size and growth. This report answers critical questions about how diagnostics can promote wellness, improve patient-provider encounters, enhance drug selection and stewardship, and facilitate future healthcare settings, including patient homes and nursing homes. It also provides insights into how diagnostics can ensure preparedness for future pandemics.
The base year for data in this report is 2022, with forecast data through 2026. Compound annual growth rates (CAGRs) are provided for each segment, and the forecasted market analysis is based on demographic trends, new developments, innovative technology, and global expansion.
Enhanced Segmentation – One Report, Multiple Insights:
Kalorama’s report offers detailed information on all major segments of point-of-care diagnostics, so you don’t need multiple reports. The report documents significant market growth changes in various categories:
- Glucose
- Coagulation
- CRP
- Other Cardiac Markers
- Colon Cancer
- Pregnancy / Fertility
- Drugs of Abuse
- hbA1c
- Cholesterol
- HIV
- COVID-19
- Other Infectious Disease
- Critical Care Tests
Key Features of the Report:
- POC Market Growth: An in-depth look at the global POC testing market over the last 20 years, highlighting the increasing demand for accurate and rapid testing both inside and outside hospital settings.
- Technological Innovations: Emerging innovations in smartphones, biosensors, lab-on-a-chip, and wearable devices are shaping the POC landscape.
- Venue Market Analysis: POC tests are performed in various settings, including hospitals, physicians’ offices, retail clinics, pharmacies, homes, and nursing homes. The report analyzes these venues and their impact on the market.
International Coverage:
Kalorama’s report reflects the global nature of the POC diagnostics market, providing regional coverage for:
- United States
- Europe
- Japan
- Rest of World
Additional countries and regions discussed include:
- Australia
- Canada
- China
- France
- Germany
- India
- Italy
- South Korea
- Spain
- Sweden
- Switzerland
- Latin America
- Middle East
Table: Global POC Test Market, 2022-2027 (in millions $)
| Year | Revenues | Percent Change |
| 2022 | $XX Million | XX% |
| 2023 | $XX Million | XX% |
| 2024 | $XX Million | XX% |
| 2025 | $XX Million | XX% |
| 2026 | $XX Million | XX% |
| 2027 | $XX Million | XX% |
| Compound Annual Growth Rate | ||
| 2022-2027 | XX% | |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
Introduction
Scope and Methodology
Size and Growth of the Market
- Table 1-1: Global POC Test Market, 2022-2027 (in millions $ at manufacturer level)
Trends Affecting the Market
Competitive Outlook
Market Conclusions
Conclusion One – POC market transformed by technological progress
Conclusion Two – POC Molecular Diagnostics continue making inroads
Conclusion Three – Prevention and early detection at nexus of POC development
Conclusion Four – Wearables continue to influence POC market
Conclusion Five – Test cost will continue to be an issue worldwide
Conclusion Six – Rising demand will drive POC market in RoW markets
Conclusion Seven – New venues – urgent & retail care
Conclusion Eight – COVID-19’s positive effect
Conclusion Nine – Insurance coverage for OTC COVID-19 testing
Conclusion Ten – New Opportunities in POC Infectious Disease Testing
Conclusion Eleven – Supply Chain Delays
Conclusion Twelve – Multiplex Testing Explodes
Conclusion Thirteen – AI Making Inroads into POC
Chapter 2: Introduction and Overview
Point-of-Care Diagnostics Testing
Industry Regulations
Types of CLIA Certificates
POC Industry Drivers
Patient focused drivers
Medical/Healthcare related drivers
Technology drivers
Economic drivers
Other drivers
POC Industry Challenges
POC Test Types
Blood
Urine
Saliva
Hair
Optical Technologies
Breath
Conditions Evaluated by POC Diagnostic Testing
Cancer
Colorectal Cancer
Prostate Cancer
Cardiovascular Disease
Diabetes
Drug Abuse
Infectious Disease
Herpes
HTLV
Respiratory Syncytial Virus
Hepatitis
Lyme Disease
Babesiosis
Gonorrhea, Syphilis and Chlamydia
Trichomonas Vaginalis
HIV/AIDS
Helicobacter Pylori
Influenza
Coronavirus
Mononucleosis
Streptococcus
Osteoporosis
Pregnancy and Fertility
Chapter 3: POC Blood Glucose Tests
Types of Blood Glucose Testing
Fasting Blood Sugar (FBS)
2-Hour Postprandial Blood Sugar (PPBS)
Random Blood Sugar
Glucose Tolerance Test
Glucose Urine Test
Glycated Hemoglobin (HbA1c)
Products
Blood Glucose Self-Testing
- Table 3-1: Selected Glucose Self-Test Meter Innovations
- Table 3-2: Selected Apps and Glucose Management IT
Continuous Self-Testing
Glycated Hemoglobin Tests
- Table 3-3: Selected POC HbA1c Devices
Professional
Market Size and Growth
- Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
- Table 3-5: Global POC Diabetes Sales by Test Category, 2022-2027 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
Regional Analysis
- Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2022 (%)
POC Glucose Self-Testing
- Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2022-2027 (in millions $ at manufacturer level)
POC Continuous Glucose Self-Testing
- Table 3-7: Global POC Continuous Glucose Self-Testing Market 2022-2027 (in millions $ at manufacturer level)
POC Glucose Professional Testing
- Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2022-2027 (in millions $ at manufacturer level)
POC HbA1c Testing
- Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2022-2027 (in millions $ at manufacturer level)
COVID-19 Impact
Competitive Analysis
- Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM,HbA1c) Revenues and Market Share of Leading Suppliers (Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others), 2022 (in millions $)
- Figure 3-2: Global POC Glucose Test Manufacturers (Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others), by Percent, 2022 (%)
Chapter 4: POC Blood and Electrolytes Testing Market
Types of Blood and Electrolytes Tests
Hemoglobin/Hematocrit
WBC and Other
Blood Gases
Electrolytes
Products
- Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2022
- Table 4-2: Selected POC Hematology Analyzer Systems, 2022
Market Size and Growth
- Table 4-3: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC, Market Analysis), 2022-2027 (in millions of dollars at the manufacturer’s level)
- Table 4-4: Global POC Blood & Electrolytes Revenues by Test Category (Blood Gases & Electrolytes, Hematocrit/Hemoglobin, WBC other routine) 2022-2027 ($ millions)
Regional Analysis
- Figure 4-1: POC Blood and Electrolytes Testing Regional Market (US, Europe, Japan, Rest of World) Analysis 2022 (%)
POC Blood and Electrolyte Self-Testing
- Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
POC Blood and Electrolyte Professional Testing
- Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
COVID-19 Impact
Competitive Analysis
- Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Other), 2022 (in millions $)
- Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers (Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Other), by Percent, 2022
Chapter 5: POC Rapid Coagulation
Products
- Table 5-1: Selected POC Coagulation Test Innovations
Platelet Testing
- Table 5-2: Selected Platelet Activity Test Innovations
Market Size and Growth
- Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
Regional Analysis
- Figure 5-1: POC Rapid Coagulation Testing Regional (US, Europe, Japan, Rest of World) Market Analysis 2022 (%)
POC Rapid Coagulation Self-Testing
- Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
POC Rapid Coagulation Professional Testing
- Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
COVID-19 Impact
Competitive Analysis
- Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Radiometer, Roche Diagnostics, Siemens Healthineers, Werfen, Others), 2022 (in millions$)
- Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers (Abbott, Radiometer, Instrumentation Labs, Roche Diagnostics, Siemens Healthineers, Others), 2022
Chapter 6: POC Rapid Cardiac Markers
Products
Market Size and Growth
- Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
Regional Analysis
- Figure 6-1: POC Rapid Cardiac Markers Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
COVID-19 Impact
Competitive Analysis
- Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers (Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others), 2022 (in millions $)
- Figure 6-2: Global POC Cardiac Markers Test Manufacturers (Abbott, QuidelOrtho, Roche, Siemens, Others), by Percent, 2022
Chapter 7: POC Substance Abuse
Overview
Products
Urine
Oral
Blood
Hair
Market Size and Growth
- Table 7-1: Global POC Drugs of Abuse Testing (critical care, employment and criminal) Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
Regional Analysis
- Figure 7-1: POC Substance Abuse Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
POC Drugs of Abuse Self-Testing
- Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2022-2027 ($ millions at the manufacturer’s level)
POC Drugs of Abuse Professional Testing
- Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
COVID-19 Impact
Competitive Analysis
- Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Roche, Siemens Healthineers, ThermoFisher, Others), 2022 (in millions of $)
- Figure 7-2: Global POC Drug of Abuse Testing Manufacturers (Abbott, Roche, Siemens Healthineers, ThermoFisher, Others), by Percent, 2022
Chapter 8: POC Pregnancy and Fertility Testing
Products
- Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device / Assay
Market Size and Growth
- Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
Regional Analysis
- Figure 8-1: POC Pregnancy and Fertility Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
POC Pregnancy and Fertility Self-Testing
- Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
POC Pregnancy and Fertility Professional Testing
- Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
COVID-19 Impact
Competitive Analysis
- Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers (bioMérieux, Church & Dwight, Meridian, Quidel, SPD, Others), 2022 (in millions $)
- Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers (bioMérieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others), by Percent, 2022
Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing
Products
- Table 9-1: Selected POC Colon Cancer Tests
Market Size and Growth
- Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2022-2027 (in millions of dollars at the manufacturer’s level)
Regional Analysis
- Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
- Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
- Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
COVID-19 Impact
Competitive Analysis
- Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers (Beckman Coulter, Exact Sciences, Others), 2022 (in millions $)
- Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers (Beckman Coulter, Exact Sciences, Others), by Percent, 2022
Chapter 10: POC Infectious Disease Testing
Products
HIV and Hepatitis
Respiratory
STD/STI
Tropical Diseases
Lyme Disease
Tuberculosis (TB)
Zika
Anthrax
Other Viruses
Hospital Acquired Infections and Sepsis
Sepsis
C.Diff
- Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
COVID-19
Antigen
Serology
Molecular
Market Size and Growth
- Table 10-2: Global POC Infectious Disease (including COVID-19) Testing Market Analysis: 2022-2027 (in millions of dollars at the manufacturer’s level)
Regional Analysis
- Figure 10-1: POC Infectious Disease (including COVID-19) Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
POC Infectious Disease Self-Testing
- Table 10-3: POC Infectious Disease Self-Testing(including COVID-19) Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
POC Infectious Disease Professional Testing
- Table 10-4: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2022-2027(in millions of dollars at the manufacturer’s level)
POC Infectious Disease Testing by Disease Type
- Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type (C. difficile, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza. Malaria, Other Respiratory, STD, Others), 2022 (in millions $)
- Figure 10-2: Global POC Infectious Disease (COVID-19, Influenza, HIV, STD, Hepatitis, Malaria, C. Diff, E. coli, H. pylori, Home Test/OTC, Others) Percent by Disease Type 2022
- Figure 10-3: Global Selected POC Infectious Disease (COVID-19, Respiratory, HIV, STD, Hepatitis, C. Diff), Percent by End-user (Hospital including reference labs, physician office labs (POL) and Nursing Homes, pharmacy, home use and others), 2022
Competitive Analysis
- Table 10-6: Global POC Infectious Disease including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others), 2022 (in millions $)
- Figure 10-4: Global POC Infectious Disease Test Manufacturers (Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others), by Percent, 2022
Chapter 11: POC Lipid Testing
Products
Market Size and Growth
- Table 11-1: Global POC Lipid Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
Regional Analysis
- Figure 11-1: POC Lipid Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
POC Lipid Self-Testing
- Table 11-2: POC Lipid Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
POC Lipid Professional Testing
- Table 11-3: POC Lipid Professional Testing Market Analysis, 2022-2027(in millions of dollars at the manufacturer’s level)
COVID-19 Impact
Competitive Analysis
- Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers 2022 (in millions $)
- Figure 11-2: Global POC Lipid Testing Manufacturers (Abaxis/Zoetis, Abbott, Roche, Others), by Percent, 2022 (%)
Chapter 12: POC Cancer Tumor Marker Testing
Products
- Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
Market Size and Growth
- Table 12-2: Global POC Cancer Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
Regional Analysis
- Figure 12-1: POC Cancer Tumor Marker Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
COVID-19 Impact
Competitive Analysis
- Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers (Beckman Coulter, bioMérieux, QuidelOrtho, Others), 2022 (in millions $)
- Figure 12-2: Global POC Cancer Testing Manufacturers (Beckman Coulter, bioMérieux, QuidelOrtho, Others), by Percent, 2022
Chapter 13: POC Urine Testing
Products
Market Size and Growth
- Table 13-1: Global POC Urine Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
Regional Analysis
- Figure 13-1: POC Urine Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
POC Urine Self-Testing
- Table 13-2: POC Urine Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
POC Urine Test Professional Testing
- Table 13-3: POC Urine Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
COVID-19 Impact
Competitive Analysis
- Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers (Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others), 2022 (in millions $)
- Figure 13-2: Global POC Urine Strip Testing Manufacturers (Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others), by Percent, 2022
Chapter 14: Miscellaneous POC Testing
Microbiology
TSH
Allergy
Autoimmune
Others
Market Size and Growth
- Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
- Table 14-2: Global POC Miscellaneous Sales, by Test Category (Microbiology, TSH, Allergy, Autoimmune, Others), 2022-2027 ($ millions)
Regional Analysis
- Figure 14-1: POC Miscellaneous Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
Chapter 15: Issues and Trends
Overview
Wearables
- Table 15-1: Selected Wearable Devices
Mobile Healthcare Technologies
Telehealth
Telehealth eMed to Implement Home Test to Treat Program
Patient-centered Healthcare
Breath Test Advances
- Table 15-2: Selected Disease Markers in Exhaled Breath
Regulatory Hurdles
Reimbursement Challenges
PAMA
Competition
POC and Molecular Diagnostics
- Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms
POC Biosensors and Microfluidics
- Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2022
- Table 15-5: Selected Biochip and Biosensor Players, 2022
China as a POC Market
Emerging POC Technologies
POC Connectivity
COVID-19 Impact
Multiplexed POC Testing
- Figure 15-1: Multiplexed POC Testing Schematic
The Emergence of Non-invasive Technologies
Saliva and Swab
Optical Techniques
Near-infrared Scanning
Volatolomics
POC and Antibiotic Resistance Concern
Artificial Intelligence in POC
POC Future in Infectious Disease Diagnostics
Supply Chain Delays
Insurance Coverage for OTC Diagnostic Tests
Chapter 16: Total Global POC Testing Market and Competitor Analysis
Market Overview
- Table 16-1: Global POC Test Market, 2022-2027 (in millions $ at manufacturer level)
Market Analysis by Product Categories
- Table 16-2: Global POC Testing Market Analysis by Product Category (Self-Testing, Professional Testing), 2022 (in millions $)
Market Analysis by Subcategory
POC Self-Testing
- Table 16-3: Global POC Self-Testing Market Analysis by Product Category (Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose including CGM, Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Other), 2022 (in millions$)
- Figure 16-1: Global POC Self-Testing Market Analysis by Product Category (Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose including CGM, Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Other), 2022 (%)
POC Professional Testing
- Table 16-4: Global POC Professional Testing Market Analysis by Product Subcategory (Blood and Electrolytes, Cancer Tumor Markers, Cardiac Markers, Drugs of Abuse, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Miscellaneous), 2022 (in millions$)
- Figure 16-2 : Global POC Professional Testing Market Analysis by Product Subcategory (Blood and Electrolytes, Cancer Tumor Markers, Cardiac Markers, Drugs of Abuse, Fecal Occult Blood, Glucose/HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Other), 2022 (by %)
POC Testing by End-Use
- Figure 16-3: POC Testing by End-User (Hospitals and Reference Labs, Nursing Homes/Pharmacies/Home, Physician Office Labs), 2022
Market by Device Technology
- Figure 16-4: Global POC Market by Technology (Analyzers, Biosensor, LFA, Strips), by Sales 2022 by %
Market Analysis by Country
United States
- Table 16-5: US POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
Europe
- Table 16-6: Europe POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
- Table 16-7: Global POC Testing Market Analysis by European Region, 2022 (in millions $)
Germany
France
UK
Switzerland and Sweden
Other
- Figure 16-5: Europe POC Testing Percentage Participation, by Country (France, Germany, Italy, Spain, Switzerland, Sweden, United Kingdom, Others), 2022 (%)
Japan
- Table 16-8: Japan POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer’s level)
Rest of World
Latin America
China
India
South Korea
Other RoW Countries
- Table 16-9: Global POC Testing Market Analysis by Rest of World Region/Country (Australia, China, India, Latin America/Middle East/Canada, South Korea/Other Asian Countries, Other), 2022 (in millions $)
- Figure 16-6: Global POC Testing Market Analysis by Rest of World Region/Country (Australia, China, India, Latin America, South Korea, Other), 2022 (%)
- Table 16-10: Global POC Testing Analysis by Region/Country (Europe, Japan, United States, Rest of World), 2022 (in millions $)
- Figure 16-7: Global POC Testing Market Analysis Percent by Region/Country (Europe, Japan, United States, Rest of World), 2022 (%)
COVID-19 Impact
Competitive Analysis
- Table 16-11: Global POC Testing Market Revenues and Market Share of Leading Suppliers (Abbott, Ascensia, Beckman Coulter, Becton Dickinson, Dexcom, Exact Sciences, Lifescan, Medtronic, QuidelOrtho, Radiometer, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Others), 2022 (in millions $)
- Figure 16-8: Global POC Testing Market Share by Leading Suppliers (Abbott, Ascensia, Beckman Coulter, Becton Dickinson, bioMérieux, Dexcom, Exact Sciences, Lifescan, Medtronic, QuidelOrtho, Radiometer, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Others), 2022 (%)
Chapter 17: Corporate Profiles
Overview
1 Step Detect Associates, LLC
- Table 17-1: 1-Step Detect Associates Corporate Summary
Company Overview
Products
Abbott Laboratories
- Table 17-2: Abbott Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-3: Abbott Revenues 2020-2022 (in millions $)
Abingdon Health Ltd.
- Table 17-4: Abingdon Health Corporate Summary
Company Overview
Products
COVID-19
AccessBio, Inc.
- Table 17-5: AccessBio Corporate Summary
Company Overview
Products
COVID-19
AccuBioTech Co, Ltd.
Table 17-6: AccuBioTech Corporate Summary
Company Overview
Products
COVID-19
ACON Laboratories, Inc
- Table 17-7: ACON Laboratories Corporate Summary
Company Overview
Products
COVID-19
Aerscher Diagnostics, LLC
- Table 17-8: Aerscher Diagnostics Corporate Summary
Company Overview
Products
Alfa Scientific Designs, Inc
- Table 17-9: Alfa Scientific Corporate Summary
Company Overview
Products
COVID-19
American Bio Medica Corporation
- Table 17-10: American Bio Medica Corporate Summary
Company Overview
Products
COVID-19
ARKRAY, Inc.
- Table 17-11: ARKRAY Corporate Summary
Company Overview
Products
Artron Laboratories, Inc
- Table 17-12: Artron Laboratories Corporate Summary
Company Overview
Products
COVID-19
Ascensia Diabetes Care Holdings AG
- Table 17-13: Ascensia Diabetes Care Corporate Summary
Company Overview
Products
Atlas Link Biotech Co., Ltd
- Table 17-14: Atlas Link Biotech Corporate Summary
Company Overview
Products
COVID-19
Autobio Diagnostics Co., Ltd
- Table 17-15: Autobio Diagnostics Corporate Summary
Company Overview
Products
COVID-19
Beckman Coulter, Inc
- Table 17-16: Beckman Coulter Corporate Summary
Company Overview
Products
COVID-19
Company Financials
- Table 17-17: Beckman Coulter Revenue (2020-2022) ($ millions)
Becton Dickinson (BD)
- Table 17-18: BD Corporate Summary
Company Overview
Products
COVID-19
Company Financials
- Table 17-19: BD Corporation Revenue (2020-2022) ($ millions)
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Table 17-20: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
Company Overview
Products
COVID-19
Bhat Bio-Tech India Private Ltd. (BBI)
- Table 17-21: Bhat Bio-Tech India Private Corporate Summary
Company Overview
Products
COVID-19
binx health
- Table 17-22: binx health Corporate Summary
Company Overview
Products
COVID-19
bioLytical Laboratories
- Table 17-23: bioLytical Laboratories Corporate Summary
Company Overview
Products
COVID-19
BioMedomics, Inc
- Table 17-24: BioMedomics Corporate Summary
Company Overview
Products
COVID-19
Biomeme, Inc
- Table 17-25: Biomeme Corporate Summary
Company Overview
Products
Biomerica, Inc.
- Table 17-26: Biomerica Corporate Summary
Company Overview
Products
COVID-19
Company Financials
- Table 17-27: Biomerica Corporation Revenue (2020-2022) ($ millions)
bioMérieux SA
- Table 17-28: bioMerieux SA Corporate Summary
Company Overview
Products
COVID-19
Company Financials
- Table 17-29: bioMerieux Revenues (2020-2022) ($ millions)
Bio-Rad Laboratories Inc.
- Table 17-30: Bio-Rad Labs Corporate Summary
Company Overview
Products
Company Financials
- Table 17-31: Bio-Rad Corporation Revenue (2020-2022) ($ millions)
Biosensia Ltd.
- Table 17-32: Biosensia Corporate Summary
Company Overview
Products
Biotron Diagnostics, Inc.
- Table 17-33: Biotron Diagnostics Corporate Summary
Company Overview
Products
Boditech Med Inc
- Table 17-34: Boditech Med Corporate Summary
Company Overview
Products
COVID-19
Boson Biotech Co. Ltd
- Table 17-35: Boson Biotech Corporate Summary
Company Overview
Products
COVID-19
BTNX Inc.
- Table 17-36: BTNX Corporate Summary
Company Overview
Products
COVID-19
Calypte Biomedical Corporation
- Table 17-37: Calypte Biomedical Corporate Summary
Company Overview
Products
Cepheid, Inc
- Table 17-38: Cephid Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-39: Cepheid Revenues (2020-2022) ($ millions)
Chembio Diagnostics, Inc.
- Table 17-40: Chembio Diagnostic Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-41: Chembio Diagnostics Revenues (2020-2022) ($ millions)
Church & Dwight Co. Inc
- Table 17-42: Church & Dwight Corporate Summary
Company Overview
Products
Performance Review
- Table 17-43: Church and Dwight Revenues (2020-2022) ($ millions)
Clarity Diagnostics, LLC
- Table 17-44: Clarity Diagnostics Corporate Summary
Company Overview
Products
COVID-19
Confirm Biosciences
- Table 17-45: Confirm Biosciences Corporate Summary
Company Overview
Products
COVID-19
CTK Biotech, Inc.
- Table 17-46: CTK Biotech Corporate Summary
Company Overview
Products
COVID-19
Cue Health
- Table 17-47: Cue Health Corporate Summary
Company Overview
Products
COVID-19
Danaher Corporation
- Table 17-48: Danaher Corporation Summary
Company Overview
Products
Dexcom, Inc
- Table 17-49: Dexcom Corporate Summary
Company Overview
Products
Performance Review
- Table 17-50: Dexcom Revenues (2020-2022) ($ millions)
DIALAB GmbH
- Table 17-51: DIALAB Corporate Summary
Company Overview
Products
COVID-19
DiaSys Diagnostic Systems GmbH
- Table 17-52: DiaSys Diagnostic Systems Corporate Summary
Company Overview
Products
COVID-19
Diazyme Laboratories, Inc.
- Table 17-53: Diazyme Laboratories Corporate Summary
Company Overview
Products
COVID-19
DNA Electronics Ltd. (DNAe)
- Table 17-54: DNA Electronics Corporate Summary
Company Overview
Products
Dr. Fooke-Achterrath Laboratorien GmbH
- Table 17-55: Dr. Fooke-Achterrath Laboratorien Corporate Summary
Company Overview
Products
COVID-19
DxGen Corp.
- Table 17-56: DxGen Corporate Summary
Company Overview
Products
COVID-19
Eiken Chemical Co Ltd.
- Table 17-57: Eiken Chemical Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-58: Eiken Chemical Revenues (2020-2022 ($ millions)
EKF Diagnostics Holdings plc
- Table 17-59: EKF Diagnostics Corporate Summary
Company Overview
Products
ELITechGroup S.A.S.
- Table 17-60: ELITechGroup Corporate Summary
Company Overview
Products
COVID-19
Enterix, Inc. (Clinical Genomics)
- Table 17-61: Enterix Corporate Summary
Company Overview
Products
Eurobio Scientific
- Table 17-62: Eurobio Scientific Corporate Summary
Company Overview
Products
COVID-19
Everlywell
- Table 17-63: Everlywell Corporate Summary
Company Overview
Products
COVID-19
Exact Sciences
- Table 17-64: Exact Sciences Corporate Summary
Company Overview
Products
Performance Review
- Table 17-65: Exact Sciences Revenues (2020-2022) ($ millions)
EY Laboratories
- Table 17-66: EY Laboratories Corporate Summary
Company Overview
Products
First Check Diagnostics LLC
- Table 17-67: First Check Diagnostics Corporate Summary
Company Overview
Products
GenBio
- Table 17-68: GenBio Corporate Summary
Company Overview
Products
Genedrive plc
- Table 17-69: Genedrive Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-70: Genedrive Revenues (2020-2022) ($ millions)
GeTein Biotech Inc.
- Table 17-71: GeTein Corporate Summary
Company Overview
Products
COVID-19
GlysBy diagnostics
- Table 17-72: GlysBy Corporate Summary
Company Overview
Products
Helena Laboratories
- Table 17-73: Helena Laboratories Corporate Summary
Company Overview
Products
Hemosure, Inc.
- Table 17-74: Hemosure Corporate Summary
Company Overview
Products
HORIBA, Ltd.
- Table 17-75: HORIBA Corporate Summary
Company Overview
Products
Performance Review
- Table 17-76: HORIBA Revenues (2020-2022) ($ millions)
Immune IQ
- Table 17-77: Immune IQ Corporate Summary
Company Overview
Products
Immunosciences Lab, Inc.
- Table 17-78: Immunosciences Lab Corporate Summary
Company Overview
Products
Immunostics, Inc
- Table 17-79: Immunostics Corporate Summary
Company Overview
Products
COVID-19
JAL Innovation PTE LTD
- Table 17-80: JAL Innovation Corporate Summary
Company Overview
Products
Jant Pharmacal Corporation
- Table 17-81: Jant Pharmacal Corporate Summary
Company Overview
Products
Mitra & Co Pvt. Ltd
- Table 17-82: J Mitra Corporate Summary
Company Overview
Products
Covid-19
LamdaGen Corporation
- Table 17-83: LamdaGen Corporate Summary
Company Overview
Products
COVID-19
LifeScan, Inc
- Table 17-84: LifeScan Corporate Summary
Company Overview
Products
LifeSign, LLC
- Table 17-85: LifeSign Corporate Summary
Company Overview
Products
COVID-19
LightDeck Diagnostics
- Table 17-86: LightDeck Diagnostics Corporate Summary
Company Overview
Products
COVID-19
LumiraDx UK Limited
- Table 17-87: LumiraDx Corporate Summary
Company Overview
Products
Performance Review
- Table 17-88: LumiraDx (2020-2022) ($ millions)
Macherey-Nagel GmbH & Co. KG
- Table 17-89: Macherey-Nagel Corporate Summary
Company Overview
Products
Medix Biochemica
- Table 17-90: Medix Biochemica Corporate Summary
Company Overview
Products
COVID-19
MedMira, Inc
- Table 17-91: MedMira Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-92: MedMira Revenues (2020-2022) ($ thousands)
Medtronic, Inc.
- Table 17-93: Medtronic Corporate Summary
Company Overview
Products
Performance Review
- Table 17-94: Medtronic Revenues (2017-2020) ($ millions)
Menarini Diagnostics srl.
- Table 17-95: Menarini Diagnostics Corporate Summary
Company Overview
Products
COVID-19
Meridian Bioscience, Inc
- Table 17-96: Meridian Bioscience Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-97: Meridian Bioscience (2020-2022) ($ millions)
MiCo BioMed USA
- Table 17-98: MiCo BioMed Summary
Company Overview
Products
Nano-Ditech Corporation
- Table 17-99: Nano-Ditech Corporate Summary
Company Overview
Products
COVID-19
NG Biotech
- Table 17-100: NG Biotech Corporate Summary
Company Overview
Products
COVID-19
Noble Medical, Inc
- Table 17-101: Noble Medical Corporate Summary
Company Overview
Products
Nova Biomedical Corp.
- Table 17-102: Nova Biomedical Corporate Summary
Company Overview
Products
Oasis Diagnostics Corporation
- Table 17-103: Oasis Diagnostics Corporate Summary
Company Overview
Products
Operon S.A.
- Table 17-104: Operon Corporate Summary
Company Overview
Products
COVID-19
OPKO Health, Inc
- Table 17-105: OPKO Health Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-106: OPKO Health Revenues (2020-2022) ($ millions)
OraSure Technologies, Inc.
- Table 17-107: OraSure Technologies Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-108: OraSure Revenues (2020-2022) ($ millions)
Polymedco, Inc
- Table 17-109: Polymedco Corporate Summary
Company Overview
Products
Polymer Technologies, Inc (PTS Diagnostics)
- Table 17-110: Polymer Technologies Corporate Summary
Company Overview
Products
COVID-19
Preventis GmbH
- Table 17-111: Preventis Corporate Summary
Company Overview
Products
Princeton Biomeditech Corporation
- Table 17-112: Princeton Biomeditech Corporate Summary
Company Overview
Products
Covid-19
QuantuMDx Group Limited
- Table 17-113: QuantuMDx Group Corporate Summary
Company Overview
Products
COVID-19
QuidelOrtho Corporation
- Table 17-114: Quidel Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-115: QuidelOrtho Revenues (2020-2022) ($ millions)
Radiometer Medical A/S
- Table 17-116: Radiometer Medical Corporate Summary
Company Overview
Products
Performance Review
- Table 17-117: Radiometer (2020-2022) ($ millions)
Randox Laboratories Limited
- Table 17-118: Randox Labs Corporate Summary
Company Overview
Products
COVID-19
Response Biomedical Corp
- Table 17-119: Response Biomedical Corporate Summary
Company Overview
Products
COVID-19
Reszon Diagnostics International Sdn. Bhd.
- Table 17-120: Reszon Diagnostics Corporate Summary
Company Overview
Products
COVID-19
Rheonix, Inc
- Table 17-121: Rheonix Corporate Summary
Company Overview
Products
COVID-19
Roche Diagnostic Corporation
- Table 17-122: Roche Diagnostic Corporate Summary
Company Overview
Products
- Table 17-123: Roche POC Marketed Products
COVID-19
Performance Review
- Table 17-124: Roche Diagnostics (2020-2022) ($ millions)
Savyon Diagnostics
- Table 17-125: Savyon Diagnostics Corporate Summary
Company Overview
Products
COVID-19
Sekisui Diagnostics LLC
- Table 17-126: Sekisui Diagnostics Corporate Summary
Company Overview
Products
Siemens Healthineers GmbH
- Table 17-127: Siemens Healthineers Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-128: Siemens Healthineers (2020-2022) ($ millions)
Sysmex Corporation
- Table 17-129: Sysmex Corporate Summary
Company Overview
Products
Performance Review
- Table 17-130: Sysmex (2020-2022) ($ millions)
TECHLAB, Inc.
- Table 17-131: TECHLAB Corporate Summary
Company Overview
Products
Trinity Biotech PLC
- Table 17-132: Trinity Biotech Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-133: Trinity Biotech Revenue (2020-2022) ($ millions)
Trividia Health
- Table 17-134: Trividia Health Corporate Summary
Company Overview
Products
Tulip Diagnostics Ltd (Tulip Group)
- Table 17-135: Tulip Diagnostics Corporate Summary
Company Overview
Product
COVID-19
VedaLab
- Table 17-136: VedaLab Corporate Summary
Company Overview
Products
COVID-19
Veredus Laboratories PTE Ltd
- Table 17-137: Veredus Labs Corporate Summary
Company Overview
Products
COVID-19
Werfen
- Table 17-138: Werfen Corporate Summary
Company Overview
Products
Performance Review
- Table 17-139: Werfen (2020-2022) ($ millions)
Related products
Cell and Gene Therapy Funding and Deals Analysis, 2021-2023
December 8, 2023
Explore the dynamic world of cell and gene therapy deal-making with Kalorama Information’s comprehensive report, Cell and Gene Therapy Funding and Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2023. This report tracks the deal-making activities in cell and gene therapy since 2021, providing insightful graphs of quarterly trends from 2021-2023 and detailing…
Price range: $5,000.00 through $7,500.00
30-Country IVD Market Atlas, 2024
December 23, 2024
With over two decades of experience in publishing in vitro diagnostic (IVD) market research, Kalorama Information presents the 30 Country In Vitro Diagnostics (IVD) Market Atlas, 2024. This quarterly updated report offers a unique approach focused on country-level research and analysis, providing a detailed analysis of major IVD segments forecasted for five years…
Price range: $5,000.00 through $7,875.00
In Vitro Diagnostics Business Outlook, 2024
December 20, 2024
In Vitro Diagnostics Business Outlook, 2024 is a must-have publication offering exclusive information and data that cannot be found elsewhere. With a focus on the in vitro diagnostics (IVD) market, this publication provides valuable insights to help businesses identify growth opportunities, understand market trends, and tailor strategies for success.
Key Features:
…
Price range: $2,950.00 through $7,500.00
